Cancer Epidemiology & Prevention (CEP) Program
癌症流行病学
基本信息
- 批准号:10438633
- 负责人:
- 金额:$ 3.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvanced Malignant NeoplasmAffectBig Data MethodsBiostatistical MethodsBiotechnologyBlack PopulationsCancer BurdenCancer Center Support GrantCancer ControlCancer EtiologyCatchment AreaCharacteristicsClinicColorectal CancerComplementComplexDataEarly DiagnosisEarly treatmentEffectivenessEnvironmental Risk FactorEpigenetic ProcessEstrogensFundingGeneticGenetic HeterogeneityGenetic RiskGenomicsGoalsHead CancerImageIncidenceIndividualIndustryInternal MedicineInternationalInterventionKnowledgeLife StyleMalignant NeoplasmsMalignant neoplasm of esophagusMalignant neoplasm of lungMalignant neoplasm of ovaryMedicalMenopauseMethodologyMinority GroupsMissionMolecularNeck CancerOncologyOnline SystemsPaperPopulationPopulation SciencesPreventionPrevention ResearchPrevention programPrevention strategyPrimary PreventionPrognostic FactorProstate Cancer therapyProteomicsPublicationsPublishingQuality of lifeRaceResearchResearch PersonnelResearch SupportResource SharingRiskRisk FactorsRisk ReductionSchoolsScienceScientistSecondary PreventionShapesSocietal FactorsStrategic visionTechniquesTechnologyTestingTobacco useTranslatingUniversity of Michigan Comprehensive Cancer CenterWorkanalytical methodanticancer researchbasecancer epidemiologycancer health disparitycancer preventioncancer riskcolorectal cancer screeningcost effectiveearly onset colorectal cancerepidemiology studyhealth disparityimaging approachimprovedimproved outcomeindividualized preventioninnovationinterestlung cancer preventionlung cancer screeningmathematical methodsmembermetabolomicsmodifiable lifestyle factorsmortalitynovelnovel chemopreventionpersonalized screeningpopulation healthpreventprogramsprotective factorsracial disparityrisk predictiontertiary preventiontool
项目摘要
PROJECT SUMMARY/ABSTRACT (CANCER EPIDEMIOLOGY AND PREVENTION)
The Cancer Epidemiology and Prevention (CEP) Program is a group of interdisciplinary population health and
medical scientists that conduct research to elucidate environmental, lifestyle and genetic causes of cancer, and
develop and test strategies and interventions to prevent and reduce the risk of cancer. CEP program members
also focus on developing statistical and mathematical approaches to advance cancer research. The program is
comprised of 29 members from 17 different departments and three schools with total annual direct research
support of $5.8 million - of which $4.7 million (81%) is from the NCI. Members are highly productive, with 533
publications during the project period, of which 17.4% are intra-programmatic and 35.3% are inter-
programmatic. Investigators are involved in intra- and inter-programmatic interactions and actively collaborate
with researchers in the other University of Michigan Comprehensive Cancer Center programs. The CEP
program has three main specific aims: 1) Elucidate risk and protective factors for common and high-mortality
cancers, with a focus on lifestyle, environmental and molecular exposures; 2) Discover and implement primary,
secondary and tertiary prevention strategies incorporating environmental and personal exposures and state-of-
the-art genomic, proteomic, metabolomic, and imaging biotechnologies; and 3) Develop and operationalize
novel biostatistical and analytic methods for big data and personalized prevention and screening.
项目摘要/摘要(癌症流行病学和预防)
癌症流行病学和预防(CEP)计划是一组跨学科的人口健康和
进行研究以阐明癌症的环境、生活方式和遗传原因的医学科学家,以及
制定和测试预防和降低癌症风险的战略和干预措施。CEP计划成员
还将重点放在开发统计和数学方法以推进癌症研究。该计划是
由来自17个不同部门和3个学院的29名成员组成,年度直接研究总额
580万美元的支持-其中470万美元(81%)来自NCI。会员工作效率很高,有533名会员
项目期间的出版物,其中17.4%是方案内出版物,35.3%是方案间出版物
程序化的。调查人员参与方案内和方案间的互动,并积极协作
与密歇根大学综合癌症中心其他项目的研究人员合作。CEP
该方案有三个主要的具体目标:1)阐明常见和高死亡率的风险和保护因素
癌症,重点关注生活方式、环境和分子暴露;2)发现和实施初级、
二级和三级预防战略,包括环境和个人暴露以及
最先进的基因组、蛋白质组、代谢组和成像生物技术;3)开发和运作
新的生物统计和分析方法,用于大数据和个性化预防和筛查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CELESTE Leigh PEARCE其他文献
CELESTE Leigh PEARCE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CELESTE Leigh PEARCE', 18)}}的其他基金
Mechanisms of Prevention of Ovarian Cancer by Oral Contraceptives
口服避孕药预防卵巢癌的机制
- 批准号:
8571076 - 财政年份:2013
- 资助金额:
$ 3.94万 - 项目类别:
A Pooled Analysis to Identify New Ovarian Cancer Risk Factors
确定新的卵巢癌危险因素的汇总分析
- 批准号:
7663022 - 财政年份:2009
- 资助金额:
$ 3.94万 - 项目类别:
The Progesterone Receptor Gene and Ovarian Cancer Risk
黄体酮受体基因与卵巢癌风险
- 批准号:
6951379 - 财政年份:2004
- 资助金额:
$ 3.94万 - 项目类别:
The Progesterone Receptor Gene and Ovarian Cancer Risk
黄体酮受体基因与卵巢癌风险
- 批准号:
6889385 - 财政年份:2004
- 资助金额:
$ 3.94万 - 项目类别:














{{item.name}}会员




